ESC 365 - COPS Trial - Colchicine to Improve Cardiovascular Outcomes in ACS Patients

ESC Premium Access

COPS Trial - Colchicine to Improve Cardiovascular Outcomes in ACS Patients

Session: Impact of Colchicine on Cardiovascular Disease

Topic: Pharmacotherapy

Speaker: Doctor J. Layland (Melbourne, AU)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Doctor Jamie Layland

Peninsula Health, Melbourne (Australia)

1 presentation

0 follower

3 more presentations in this session

Online Session - Impact of Colchicine on Cardiovascular Disease - Host and discussant

Speaker: Professor M. Imazio (Udine, IT)

COLCOT Pharmacogenomics

Speaker: Professor M. Dube (Montreal, CA)

Impact of time-to-treatment initiation of colchicine on cardiovascular outcomes after myocardial infarction: insights from the Colchicine Cardiovascular Outcomes Trial (COLCOT)

Speaker: Doctor N. Bouabdallaoui (Montreal, CA)

Access the full session

Impact of Colchicine on Cardiovascular Disease

Speakers: Doctor J. Layland, Professor M. Imazio, Professor M. Dube, Doctor N. Bouabdallaoui

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources